676
Views
36
CrossRef citations to date
0
Altmetric
Treatment: Retention

Effectiveness of Therapies for Heroin Addiction in Retaining Patients in Treatment: Results From the VEdeTTE Study

, , , , , , , , , & show all
Pages 2076-2092 | Published online: 03 May 2010

References

  • Amato, L., Davoli, M., Minozzi, S., Ali, R., Ferri, M. (2005). Methadone at tapered doses for the management of opioid withdrawal. The Cochrane Database of Systematic Reviews, (3) CD003409.
  • Amato, L., Davoli, M., Ferri, M., Gowing, L., Perucci, C. A. (2004). Effectiveness of interventions on opiate withdrawal treatment: an overview of systematic reviews. Drug and Alcohol Dependence, 73(3):219–226.
  • Amato, L., Minozzi, S., Davoli, M., Vecchi, S., Ferri, M., Mayet, S. (2008). Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence. The Cochrane Database of Systematic Reviews, (4) CD004147.
  • Bargagli, A. M., Faggiano, F., Amato, L., Salamina, G., Davoli, D., Mathis, F., (2006). VEdeTTE, a longitudinal study on effectiveness of treatments for heroin addiction in Italy: study protocol and characteristic of study population. Substance Use and Misuse, 41:1861–1879
  • Caplehorn, J. R. M., McNeil, D., Kleinbaum, D. G. (1993). Clinic policy and retention in methadone maintenance. International Journal of the Addictions, 28(1):73–89
  • Davoli, M., Bargagli, A. M., Perucci, C. A., Schifano, P., Belleudi, V., Hickman, M., Salamina, G., Diecidue, R., Vigna-Taglianti, F., and Faggiano, F., for the VE de TTE Study Group. Risk of fatal overdose during and after specialist drug treatment: the VEdeTTE Study, a national multisite prospective cohort study. Addiction, 102: 1954–1959.
  • D’Ippoliti, D., Davoli, M., Perucci, C. A., Pasqualini, F., Bargagli, A. M. (1998). Retention in treatment of heroin users in Italy: the role of treatment type and of methadone maintenance dosage. Drug and Alcohol Dependence, 52:167–171.
  • Faggiano, F., Vigna-Taglianti, F., Versino, E., Lemma, P. (2003). Methadone maintenance at different dosages for opiod dependence. The Cochrane Database of Systematic Reviews, (3): CD002208.
  • Gossop, M., Marsden, J., Stewart, D., Treacy, S. (2001). Outcomes after methadone maintenance and methadone reduction treatments: two year follow-up results from the National Treatment Outcome Research Study. Drug and Alcohol Dependence, 62:255–264.
  • Johnson, R. E., Chutuape, M. A., Strain, E. C., Walsh, S. L., Stitzer, M. L., Bigelow, G. E. (2000). A comparison of levomethadyl acetate, buprenorphine and methadone for opiod dependence. New England Journal of Medicine, 343:1290–1297.
  • Johnson, R. E., Jaffe, J. H., Fudala, P. J. (1992). A controlled trial of buprenorphine treatment for opioid dependence. JAMA, 267(20):2750–2755.
  • Kleinbaum, D. G. (1996). Survival analysis. New York: Springer.
  • Leshner, A. I. (1997). Drug abuse and addiction treatment research: the next generation. Archives of General Psychiatry, 54:691–694.
  • Marsch, L. A. (1998). The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis. Addiction, 93(4):73–92.
  • Mattick, R. P., Breen, C., Kimber, J., Davoli, M. (2009). Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. The Cochrane Database of Systematic Reviews, (3): CD002209.
  • McLellan, A. T. (2002). Have we evaluated addiction treatment correctly? Implications from a chronic care perspective. Addiction, 97:249–252.
  • McLellan, A. T., Arndt, I. O., Metzger, D. S., Woody, G. E., O’ Brien C. P. (1993). The effects of psychosocial services in substance abuse treatment. JAMA, 269(15):1953–1959.
  • McLellan, A. T., O’Brien, C. P., Lewis, D., Kleber, H. D. (2000). Drug addiction as a chronic medical illness: implications for treatment, insurance and evaluation. JAMA, 284:1689–1695.
  • Ministero della Solidarietà Sociale. (2006). Relazione annuale al parlamento sullo stato delle tossicodipendenze in Italia, 2005. Ministero Solidarietà Sociale, Roma.
  • NIDA.nih.gov. (2000). Principles of drug addiction treatment. Bethesda: National Institute of Health Press. Accessed 9 April 2010 from http://www.drugabuse.gov/PODAT/PODATindex.html.
  • Simpson, D. D., Joe, G. W., Broome, K. M., Hiller, M. L., Knight, K., Rowan-Szal, G. A. (1997a). Program diversity and treatment retention rates in the Drug Abuse Treatment Outcome Study (DATOS). Psychology Addictive Behaviors, 11(4):279–293.
  • Simpson, D. D., Joe, G. W., Brown, B. S. (1997b). Treatment retention and follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychology Addictive Behaviors, 11(4):294–307.
  • Stout, R. L., Rubin, A., Zwick, W., Zywiak, W., Bellino, L. (1999). Optimizing the cost effectiveness of alcohol treatment: a rationale for extended case monitoring. Addictive Behaviors 24:17–35.
  • Strain, E. C., Bigelow, G. E., Liebson, I. A., Stitzer, M. L. (1999). Moderate- vs high-dose methadone in the treatment of opioid dependence: a randomized trial. JAMA, 281(11):1000–1005.
  • Strain, E., Stitzer, M., Leibson, I., Bigelow, G. (1993). Dose-response effects of methadone in the treatment of opioid dependence. Annals of Internal Medicine, 119:23–27.
  • Vanichseni, S., Wongsuwan, B., The Staff of BMA Narcotics Clinic No. 6, Choopanya, K., Wongpanich, K. (1991). A controlled trial of methadone in a population of intravenous drug users in Bangkok: implications for prevention of HIV. International Journal of the Addictions, 26(12):1313–1320.
  • Ward, J., Hall, W., Mattick, R. P. (1999). Role of maintenance treatment in opioid dependence. Lancet, 353(9148):221–226
  • Yancovitz, S., Des Jarlais, D., Peskoe Peyser, N., Drew, E., Friedman, P., Trigg, H., (1991). A randomized trial of an interim methadone maintenance clinic. American Journal of Public Health, 81:1185–1191.
  • Zhang, Z., Friedmann, P. D., Gerstein, D. R. (2003). Does retention matter? Treatment duration and improvement in drug use. Addiction, 98(5):673–684.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.